CAMBRIDGE, MA, Biorithm has announced a $3.5M Series A Funding co-led by Adaptive Capital Partners and SEEDS Capital.
Biotithm has closed a $3.5 million Series A funding co-led by Adaptive Capital Partners and SEEDS Capital.
Biorithm is committed to ending preventable pregnancy complications by pioneering new standards of care through protocol-based remote monitoring of maternal and fetal biometrics.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
